ABMs have also been used to investigate the immune response to various cancer treatements; in [12], G. Chang et al. study the spatial patterns of PD-L1, a molecule involved in immune checkpoints, which provides a framework to test and compare predictive biomarkers for various cancer treatments. This evidence concerns the gene CD274 and cancer.